Last reviewed · How we verify
A Study for Post op Inflammation After Cataract Surgery
This is a randomized, controlled study to assess the safety and effectiveness of treatment with an intracanalicular dexamethasone (0.4mg) insert when utilized in conjunction with topical steroids as part of an extended taper steroid regimen following cataract surgery in patients with a history of epiretinal membrane, diabetic retinopathy, or non-exudative macular degeneration.
Details
| Lead sponsor | Wyse Eyecare |
|---|---|
| Phase | PHASE4 |
| Status | UNKNOWN |
| Enrolment | 40 |
| Start date | Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Cataract
Interventions
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1%
Countries
United States